We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Wyndham Hotels & Resorts
WH
$5.58B
| $20.5M | 0.03% |
264,954
-4,059
| -2% | -$291K |
|
577
Henry Schein
HSIC
$9.83B
| $20.4M | 0.03% |
268,457
-12,700
| -5% | -$977K |
|
578
PTC
PTC
$16B
| $20.4M | 0.03% |
170,491
+11,474
| +7% | +$1.53M |
|
579
Commerce Bancshares
CBSH
$8.51B
| $20.3M | 0.03% |
371,559
-10,339
| -3% | -$570K |
|
580
Fortune Brands Innovations
FBIN
$6.01B
| $20.2M | 0.03% |
264,569
-5,096
| -2% | -$424K |
|
581
Concentrix
CNXC
$1.61B
| $20.1M | 0.03% |
113,840
-1,746
| -2% | -$289K |
|
582
Landstar System
LSTR
$6.01B
| $20.1M | 0.03% |
127,497
+7,807
| +7% | +$1.25M |
|
583
Globe Life
GL
$14.4B
| $20.1M | 0.03% |
225,837
-3,956
| -2% | -$370K |
|
584
XPO
XPO
$23B
| $20.1M | 0.03% |
424,294
-320,468
| -43% | -$16.1M |
|
585
Loews
L
$23.7B
| $20M | 0.03% |
371,486
-32,042
| -8% | -$1.74M |
|
586
Jefferies Financial Group
JEF
$13B
| $20M | 0.03% |
564,080
-21,228
| -4% | -$710K |
|
587
Zscaler
ZS
$26.3B
| $20M | 0.03% |
76,329
-512
| -0.7% | -$129K |
|
588
Lumen
LUMN
$6.09B
| $20M | 0.03% |
1,614,956
-27,446
| -2% | -$344K |
|
589
Pultegroup
PHM
$24.7B
| $20M | 0.03% |
435,251
-9,422
| -2% | -$490K |
|
590
Jazz Pharmaceuticals
JAZZ
$16.7B
| $20M | 0.03% |
153,324
-4,101
| -3% | -$620K |
|
591
Insulet
PODD
$9.66B
| $19.9M | 0.03% |
70,024
-515
| -0.7% | -$147K |
|
592
Fox Class A
FOXA
$25.9B
| $19.9M | 0.03% |
495,830
-28,278
| -5% | -$1.04M |
|
593
Prosperity Bancshares
PB
$8.88B
| $19.9M | 0.03% |
279,585
+15,181
| +6% | +$1.05M |
|
|
WRK
594
DELISTED
WestRock Company
WRK
| $19.9M | 0.03% |
398,397
-14,391
| -3% | -$727K |
|
595
Maximus
MMS
$3.06B
| $19.8M | 0.03% |
238,272
+24,863
| +12% | +$2.13M |
|
596
Omega Healthcare
OHI
$14.8B
| $19.8M | 0.03% |
660,657
-10,101
| -2% | -$348K |
|
597
EastGroup Properties
EGP
$10.8B
| $19.8M | 0.03% |
118,659
+731
| +0.6% | +$127K |
|
598
Kohl's
KSS
$2.09B
| $19.8M | 0.03% |
419,799
-13,427
| -3% | -$718K |
|
599
Dick's Sporting Goods
DKS
$17.8B
| $19.7M | 0.03% |
164,356
-7,197
| -4% | -$837K |
|
600
Reinsurance Group of America
RGA
$15.5B
| $19.7M | 0.03% |
176,807
-6,693
| -4% | -$762K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.